1-3 of 3
Hiraku Takei
Close
Sort by
Journal Articles

The Zygosity of JAK2 V617F Determines the Disease Entities of Myeloproliferative Neoplasms By Modulating Erythropoiesis but Not Megakaryopoiesis

Hiraku Takei, MS, Yoko Edahiro, MD PhD, Lihua Li, PhD, Yoshihisa Mizukami, PhD, Misa Imai, PhD, Soji Morishita, PhD, Akimichi Ohsaka, MD PhD, Marito Araki, PhD, Norio Komatsu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3068.
https://doi.org/10.1182/blood-2018-99-112419
Published: 2018
Journal Articles

Localization of Mutant Calreticulin in the Golgi Apparatus Is Required for Its Oncogenic Capacity

Nami Masubuchi, Marito Araki, PhD, Erina Hayashi, BS, Yinjie Yang, PhD, Misa Imai, PhD, Yoshihiko Kihara, PhD, Yoshihisa Mizukami, PhD, Yumi Hironaka, BS, Hiraku Takei, MS, Yoko Edahiro, PhD, Akimichi Ohsaka, MD PhD, Norio Komatsu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1656.
https://doi.org/10.1182/blood.V130.Suppl_1.1656.1656
Published: 2017
Journal Articles

Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms

Marito Araki, Yinjie Yang, Nami Masubuchi, Yumi Hironaka, Hiraku Takei, Soji Morishita, Yoshihisa Mizukami, Shin Kan, Shuichi Shirane, Yoko Edahiro, Yoshitaka Sunami, Akimichi Ohsaka, Norio Komatsu
Journal: Blood
Blood (2016) 127 (10): 1307–1316.
https://doi.org/10.1182/blood-2015-09-671172
Published: 2016
Includes: Supplemental data